How many insider declarations has Adam Craig filed?

Adam Craig has filed 1 public insider declaration with SEC (Form 4).

What is Adam Craig's role?

Adam Craig's reported role is not specified by the regulator across the filings.

Which companies does Adam Craig report trades for?

Adam Craig reports trades for X4 Pharmaceuticals, Inc.

← Executives ★ Sign in to follow

AC

Adam Craig

·SEC (Form 4)

X4 Pharmaceuticals, Inc

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Adam Craig. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 1 filings have been published. History available since 12 August 2026. The latest transaction was filed on 12 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Adam Craig

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

X4 Pharmaceuticals, Inc (US)

Declarations1 total

●

Adam Craig

Executive ChaimanExecutives12 Aug 2026X4 Pharmaceuticals, Inc

$216,0710Source ↗

47,436 shares@ US$4.555Common StockSEC144:0001339498-26-000003

1 of 1 declaration

InsidersTradesSigma

← Executives ★ Sign in to follow

AC

Adam Craig

·SEC (Form 4)

X4 Pharmaceuticals, Inc

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Adam Craig. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 1 filings have been published. History available since 12 August 2026. The latest transaction was filed on 12 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.